{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:13Z","timestamp":1792182313360,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T00:00:00Z","timestamp":1424908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00204-015-1483-z","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T23:26:50Z","timestamp":1424820410000},"page":"677-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells"],"prefix":"10.1007","volume":"90","author":[{"given":"Robim M.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Branson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"De Boe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agapios","family":"Sachinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Rogiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joery","family":"De Kock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"issue":"8","key":"1483_CR1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/17425255.2011.577740","volume":"7","author":"DE Amacher","year":"2011","unstructured":"Amacher DE (2011) The mechanistic basis for the induction of hepatic steatosis by xenobiotics. Exp Opin Drug Metab Toxicol 7(8):949\u2013965. doi: 10.1517\/17425255.2011.577740","journal-title":"Exp Opin Drug Metab Toxicol"},{"key":"1483_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/faat.1997.2389","volume":"40","author":"DE Amacher","year":"1997","unstructured":"Amacher DE, Martin BA (1997) Tetracycline-induced steatosis in primary canine hepatocyte cultures. Fundam Appl Toxicol 40:256\u2013263. doi: 10.1006\/faat.1997.2389","journal-title":"Fundam Appl Toxicol"},{"key":"1483_CR3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/pr.108.00001","volume":"60","author":"N Anderson","year":"2008","unstructured":"Anderson N, Borlak J (2008) Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 60:311\u2013357. doi: 10.1124\/pr.108.00001","journal-title":"Pharmacol Rev"},{"issue":"16","key":"1483_CR4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346(16):1221\u20131231. doi: 10.1056\/NEJMra011775","journal-title":"N Engl J Med"},{"key":"1483_CR5","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep.24290","volume":"53","author":"S Antherieu","year":"2011","unstructured":"Antherieu S, Rogue A, Fromenty B, Guillouzo A, Robin MA (2011) Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG Cells. Hepatology 53:1895\u20131905. doi: 10.1002\/hep.24290","journal-title":"Hepatology"},{"key":"1483_CR6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.scr.2010.02.002","volume":"5","author":"MA Baxter","year":"2010","unstructured":"Baxter MA, Rowe C, Alder J, Harrison S, Hanley KP, Park BK, Kitteringham NR, Goldring CE, Hanley NA (2010) Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res 5:4\u201322. doi: 10.1016\/j.scr.2010.02.002","journal-title":"Stem Cell Res"},{"key":"1483_CR7","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467\u20132474. doi: 10.1016\/s0002-9270(99)00433-5","journal-title":"Am J Gastroenterol"},{"key":"1483_CR8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","volume":"141","author":"MR Charlton","year":"2011","unstructured":"Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA (2011) Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141:1249\u20131253. doi: 10.1053\/j.gastro.2011.06.061","journal-title":"Gastroenterology"},{"key":"1483_CR9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfh100","volume":"79","author":"JC Davila","year":"2004","unstructured":"Davila JC, Cezar GG, Thiede M, Strom S, Miki T, Trosko J (2004) Use and application of stem cells in toxicology. Toxicol Sci 79:214\u2013223. doi: 10.1093\/toxsci\/kfh100","journal-title":"Toxicol Sci"},{"key":"1483_CR10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2174\/138920012802850001","volume":"13","author":"MT Donato","year":"2012","unstructured":"Donato MT, Jose Gomez-Lechon M (2012) Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates. Curr Drug Metab 13:1160\u20131173. doi: 10.2174\/138920012802850001","journal-title":"Curr Drug Metab"},{"key":"1483_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cbi.2009.07.019","volume":"181","author":"MT Donato","year":"2009","unstructured":"Donato MT, Martinez-Romero A, Jimenez N, Negro A, Herrera G, Castell JV, O\u2019Connor J-E, Jose Gomez-Lechon M (2009) Cytometric analysis for drug-induced steatosis in HepG2 cells. Chem Biol Interact 181:417\u2013423. doi: 10.1016\/j.cbi.2009.07.019","journal-title":"Chem Biol Interact"},{"key":"1483_CR12","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph L (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557\u20132576. doi: 10.1053\/j.gastro.2007.04.061","journal-title":"Gastroenterology"},{"key":"1483_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","volume":"610","author":"C Guguen-Guillouzo","year":"2010","unstructured":"Guguen-Guillouzo C, Guillouzo A (2010) General review on in vitro hepatocyte models and their applications. Methods Mol Biol 610:1\u201340. doi: 10.1007\/978-1-60761-688-7_1","journal-title":"Methods Mol Biol"},{"key":"1483_CR14","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","volume":"98","author":"SA Harrison","year":"2003","unstructured":"Harrison SA, Torgerson S, Hayashi PH (2003) The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98:2042\u20132047. doi: 10.1016\/s0002-9270(03)00622-1","journal-title":"Am J Gastroenterol"},{"key":"1483_CR15","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of affymetrix GeneChip probe level data. Nucleic Acids Res. doi: 10.1093\/nar\/gng015","journal-title":"Nucleic Acids Res"},{"key":"1483_CR16","unstructured":"Kacew S, Lee BM (2013) Lu\u2019s basic toxicology: fundamentals, target organs, and risk assessment, 6th edition Sam Kacew, Byung-Mu Lee. edition London: Informa Healthcare, pp 170\u2013179"},{"key":"1483_CR17","first-page":"192","volume":"10","author":"DE Kleiner","year":"1997","unstructured":"Kleiner DE, Gaffey MJ, Sallie R, Tsokos M, Nichols L, McKenzie R, Straus SE, Hoofnagle JH (1997) Histopathologic changes associated with fialuridine hepatotoxicity. Mod Pathol 10:192\u2013199","journal-title":"Mod Pathol"},{"key":"1483_CR18","volume-title":"Description of prototype modes-of-action related to repeated dose toxicity","author":"B Landesmann","year":"2012","unstructured":"Landesmann B, Goumenou M, Munn S, Whelan M (2012) Description of prototype modes-of-action related to repeated dose toxicity. JRC Sci Policy Report 75689"},{"key":"1483_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60761-688-7_3","volume":"640","author":"EL LeCluyse","year":"2010","unstructured":"LeCluyse EL, Alexandre E (2010) Isolation and culture of primary hepatocytes from resected human liver tissue. Methods Mol Biol 640:57\u201382. doi: 10.1007\/978-1-60761-688-7_3","journal-title":"Methods Mol Biol"},{"key":"1483_CR20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413\u20131419. doi: 10.1016\/S0016-5085(99)70506-8","journal-title":"Gastroenterology"},{"key":"1483_CR21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","volume":"59","author":"CA Moylan","year":"2014","unstructured":"Moylan CA, Pang H, Dellinger A, Suzuki A, Garrett ME, Guy CD, Murphy SK, Ashley-Koch AE, Choi SS, Michelotti GA, Hampton DD, Chen Y, Tillmann HL, Hauser MA, Abdelmalek MF, Diehl AM (2014) Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 59:471\u2013482. doi: 10.1002\/hep.26661","journal-title":"Hepatology"},{"key":"1483_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0163-7827(01)00013-3","volume":"40","author":"DJ Murphy","year":"2001","unstructured":"Murphy DJ (2001) The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog Lipid Res 40:325\u2013438. doi: 10.1016\/s0163-7827(01)00013-3","journal-title":"Prog Lipid Res"},{"key":"1483_CR23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cld.2012.05.006","volume":"16","author":"MR Pagadala","year":"2012","unstructured":"Pagadala MR, McCullough AJ (2012) The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis 16:487\u2013504. doi: 10.1016\/j.cld.2012.05.006","journal-title":"Clin Liver Dis"},{"key":"1483_CR24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00204-014-1199-5","volume":"88","author":"RM Rodrigues","year":"2014","unstructured":"Rodrigues RM, De Kock J (2014) Human stem cell-derived hepatocytes: breakthrough of an expedient tool for preclinical assessment of drug-induced liver injury? Arch Toxicol 88:183\u2013184. doi: 10.1007\/s00204-014-1199-5","journal-title":"Arch Toxicol"},{"key":"1483_CR25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/scd.2013.0157","volume":"23","author":"RM Rodrigues","year":"2014","unstructured":"Rodrigues RM, De Kock J, Branson S, Vinken M, Meganathan K, Chaudhari U, Sachinidis A, Govaere O, Roskams T, De Boe V, Vanhaecke T, Rogiers V (2014) Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals. Stem Cells Dev 23:44\u201355. doi: 10.1089\/scd.2013.0157","journal-title":"Stem Cells Dev"},{"key":"1483_CR26","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2174\/138161205774414510","volume":"11","author":"D Schuster","year":"2005","unstructured":"Schuster D, Laggner C, Langer T (2005) Why drugs fail\u2014a study on side effects in new chemical entities. Curr Pharm Des 11:3545\u20133559","journal-title":"Curr Pharm Des"},{"key":"1483_CR27","first-page":"500","volume":"86","author":"DA Scott","year":"1991","unstructured":"Scott DA, Gholson CF, Netchvolodoff CV, Ray M, Gonzalez E, Bacon BR (1991) Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy. Am J Gastroenterol 86:500\u2013502","journal-title":"Am J Gastroenterol"},{"key":"1483_CR28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/stemcells.2008-0963","volume":"27","author":"S Snykers","year":"2009","unstructured":"Snykers S, De Kock J, Rogiers V, Vanhaecke T (2009) In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 27:577\u2013605. doi: 10.1634\/stemcells.2008-0963","journal-title":"Stem Cells"},{"key":"1483_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5966\/sctm.2013-0146","volume":"3","author":"D Szkolnicka","year":"2014","unstructured":"Szkolnicka D, Farnworth SL, Lucendo-Villarin B, Storck C, Zhou WL, Iredale JP, Flint O, Hay DC (2014) Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med 3:141\u2013148. doi: 10.5966\/sctm.2013-0146","journal-title":"Stem Cells Transl Med"},{"key":"1483_CR30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mnfr.200900169","volume":"54","author":"T Uehara","year":"2010","unstructured":"Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, Urushidani T (2010) The Japanese toxicogenomics project: application of toxicogenomics. Mol Nutr Food Res 54:218\u2013227. doi: 10.1002\/mnfr.200900169","journal-title":"Mol Nutr Food Res"},{"key":"1483_CR31","unstructured":"Uetrecht J, Pessayre D, Mansouri A, Berson A, Fromenty B (2010) Mitochondrial involvement in drug-induced liver injury. Adverse Drug Reactions. Springer, Berlin, pp 311\u2013365"},{"key":"1483_CR32","doi-asserted-by":"crossref","unstructured":"Urushidani T, Nagao T (2005) Toxicogenomics: Japanese initiative. Handbook of toxicogenomics. Wiley-VCH Verlag GmbH & Co. KGaA, pp 623\u2013631. doi: 10.1002\/3527603719.ch26","DOI":"10.1002\/3527603719.ch26"},{"key":"1483_CR33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","volume":"312","author":"M Vinken","year":"2013","unstructured":"Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158\u2013165. doi: 10.1016\/j.tox.2013.08.011","journal-title":"Toxicology"},{"key":"1483_CR34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1091983","volume":"28","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska A, Feldstein AE (2008) Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28:386\u2013395. doi: 10.1055\/s-0028-1091983","journal-title":"Semin Liver Dis"},{"key":"1483_CR35","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/cr.2009.73","volume":"19","author":"H Wobser","year":"2009","unstructured":"Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Buttner R, Scholmerich J, Hellerbrand C (2009) Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res 19:996\u20131005. doi: 10.1038\/cr.2009.73","journal-title":"Cell Res"},{"key":"1483_CR36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/bega.2002.0334","volume":"16","author":"WI Youssef","year":"2002","unstructured":"Youssef WI, McCullough AJ (2002) Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol 16:733\u2013747. doi: 10.1053\/bega.2002.0334","journal-title":"Best Pract Res Clin Gastroenterol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1483-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-015-1483-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1483-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:17:08Z","timestamp":1558624628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-015-1483-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1007\/s00204-015-1483-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}